Ara
Toplam kayıt 84, listelenen: 81-84
Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study
(2013)
Amaç: YKL-40, yeni bir yerel enflamasyon biyobelirteci, aterosklerotik plaklar içerisinde makrofajlar tarafından salınırlar. Koroner arter ektazisi (KAE) etyopatogenezisi kesin olarak ortaya konulmamış klinik bir antitedir. ...
Increased serum resistin levels in patients with coronary slow-flow phenomenon
(Urban und Vogel GmbH, 2013)
Background. Slow coronary flow (SCF) is an angiographic finding characterized by delayed opacification of the epicardial coronary arteries without obstructive coronary disease. Resistin, an adipocytokine, plays a major ...
Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI
(Springer Link, 2013)
Background: Macrophages in atherosclerotic plaques secrete YKL-40, a new biomarker of acute and chronic inflammation in patients with stable CAD. We hypothesized that YKL-40 may be a specific marker reflecting the burden ...
Hepatic effects of ketamine administration for 2 weeks in rats
(Sage Publishing, 2014)
The aim of the present study was to investigate the long-term and high-dose application of ketamine on the liver by employing histologic and biochemical methods. A total of 30 male rats were randomly assigned to control ...